Table 2

Summary of subscale responses

NEI VFQ-25 Subscale	All BRVO patients		Reference group			Diabetic retinopathy			CRVO			AMD			LV
NEI VFQ-25 Subscale	N=46		N=22		p Value	N=123		p Value	N=51		p Value	N=108		p Value	N=90		p Value
General health	61.4	(20.9)	69	(24)	0.047	46	(25)	<0.001	51	(29)	0.044	65	(25)	0.359	57	(27)	0.296
General vision	67.8	(15.5)	83	(15)	<0.001	62	(21)	0.053	58	(23)	0.015	53	(20)	<0.001	38	(18)	<0.001
Near vision	72.8	(18.9)	92	(13)	<0.001	63	(30)	0.013	62	(32)	0.044	54	(27)	<0.001	36	(23)	<0.001
Distance vision	77.2	(18.8)	93	(11)	<0.001	66	(30)	0.004	67	(28)	0.036	56	(29)	<0.001	38	(26)	<0.001
Driving	75.3	(23.6)	87	(18)	0.003	55	(40)	<0.001	50	(39)	<0.001	39	(36)	<0.001	10	(23)	<0.001
Peripheral vision	83.2	(20.4)	97	(10)	<0.001	78	(29)	0.195	65	(27)	<0.001	77	(27)	0.122	59	(32)	<0.001
Colour vision	96.7	(12.5)	98	(8)	0.514	90	(22)	0.015	80	(30)	0.001	85	(25)	<0.001	71	(31)	<0.001
Ocular pain	76.6	(20.2)	90	(5)	<0.001	88	(17)	0.001	85	(18)	0.034	87	(16)	0.003	85	(20)	0.024
Role difficulties	75.0	(27.0)	93	(13)	<0.001	69	(31)	0.221	63	(32)	0.048	61	(31)	0.006	44	(29)	<0.001
Dependency	91.7	(19.1)	99	(6)	0.014	77	(30)	<0.001	69	(34)	<0.001	72	(30)	<0.001	51	(31)	<0.001
Social functioning	94.0	(12.8)	99	(3)	0.012	81	(26)	<0.001	70	(30)	<0.001	73	(29)	<0.001	50	(31)	<0.001
Mental health	73.8	(20.9)	92	(12)	<0.001	66	(29)	0.056	60	(28)	0.007	58	(27)	<0.001	46	(27)	<0.001

p Values are based on a t test comparison with the branch retinal vein occlusion (BRVO) group. Data are given as mean (SD).
AMD, age-related macular degeneration; CRVO, central vein occlusion; LV, low vision; NEI VFQ-25, National Eye Institute 25-Item Visual Function Questionnaire.